Note about delegations (autosaves; send when ready)
Strategy
2 active · 12 total
Proposed for next Fri 14:00: Bad Orb (rank 1) — urgent, important, big; momentum live. Grants (rank 2, hard deadlines) right after.
Work next — ranked
NEXTBad Orburgentself-imposed
German consolidation step — pulls Beyond + medneo + Am Turm into one place; local doctor runs the FFM back-office.
Generates revenue + de-risks the uni exit; bridges to the Mojácar longevity centre. Next: Eike's concrete move after the Strauss/Adel chats.
Grantshighhard deadline
The funding ladder — €2.5M survival (2031–40) / €10–20M ambition. EN = AI-imaging, VP = trials.
Assembly started 2026-06-05 — keep momentum; longlist sequencing + DFG HFpEF Methods rewrite. Submission dates are hard.
In the queue (not yet discussed)
Cooperations — Partners in the line: Bender/Loewe IBT, Heidelberg (CMR clinical + AI), Messina, Berlin (Kelle), HZ Bad Bevensen, Berlin (AI). Scaffolding at 40-infrastructure/research-politics/cooperations/. ⛔ Eike's meta-answer — per partner, what's the goal (data / grant co-app / IP)?
MR-vendor strategy — Get a real alternative / second source away from the majors. Lens: field strength, cost, CMR depth, openness to external tools (own feedback loop + AI-supported scanning). Narrow eval to Canon Vantage Galan 3T + United Imaging 5T vs Siemens/GE baseline — see § MR vendor landscape below.
DZHK Professorenkonferenz — speaker role — Eike is now speaker of the DZHK professors. Where's the leverage (Vorstand seat? agenda-setting? influence?) and what's the agenda — research-political reform, member advocacy, scientific direction, governance reform?
DZHK HFpEF focus-area (Focus group) — Focus-area co-lead governance + cluster map. Strategic positioning question — how to shape the focus group's direction and Eike/VP's role in it. Scaffolding at 40-infrastructure/research-politics/dzhk-hfpef-focus-area/.
CMR-AI product roadmap (Goethe CVI) — The spinoff product arc on top of the contour engine — what ships, in what order, MDR/FDA sequencing. Overlaps Contours + Imaging Project.
trAIectories — New company? The persistent software layer (clinical-case-UI / trAIectory app) that runs on top of both Bad Orb and Mojácar — decide whether it's its own vehicle.
Longevity / Mojácar (long-term) — The destination longevity centre (Spain) that Bad Orb funds the path to. Long-horizon; the eventual flagship.
Branding — Eike + VP personal brand — uni prof + scientist + high-end practice + healthy-lifespan, AI-supported, evidence-based. Peter-Attia-style with chair-level research credentials. The brand is the people. Overlaps Bad Orb.
Show actioned — no intervention until trigger (2)
Full Imaging Projectuntil: Gantt needs a review
Milestones/timeframes/Gantt worked 2026-06-05; execution now flows via delegations + action points, not strategy.
Company sell-blocker #1, but the strategy call (two-track: nnU-Net product + interactive correction; CineMA as pre-segmenter) is made. Execution is Raphael/Luisa. Includes "how to finalize the contours" (Goethe CVI).
Add by dropping @strategy <topic> into any STATE.md, talkback, or tell Claude. Ranks, deadlines & states live in _morning/STRATEGY.md (Claude-maintained).
Note about Strategy (autosaves; send when ready)
Talk back to brain
free-form
For things not in any list above. Type freely, pick a prefix, send. Autosaves between sessions.
Conventions: ?c? = discuss · @c = autonomous Claude action · @strategy = move to Strategy queue · ## TODO Claude = longer prompts.
Ticked items hide + queue in browser → tap "Send to brain →" to fire one batch email.
⚠ brain-daily issues today (3) — click to expand
(resolved this session) ESC inbox-folder filename names = authors, shareable — no DSGVO block; recorded in prevention-book-chapter STATE so it won't re-flag.
(resolved this session) STRATEGY.md Friday header advanced to Fri 12 Jun; STRATEGY.md is now Claude-maintained (SYSTEM.md §7).
One manual web step pending for Eike: delete the old `brain-en` site at app.netlify.com (Netlify fully removed brain-side; dead end).